malegra50pilll

The expiration of Malegra 50 Mg’s patent signifies the end of its exclusivity. This opens the door for generic versions of the drug to be manufactured and sold by other companies, often at a significantly lower cost. For consumers, this change can mean greater accessibility and affordability. For manufacturers, however, it marks a shift in market dynamics and competition.